Epidiolex (cannabidiol) is a prescription medicine used to treat seizures in people with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex.
Epidiolex is for use in adults and children who are at least 1 year old.
In April 2020, the U.S. Drug Enforcement Administration (DEA) announced the removal of cannabidiol from Schedule V of the Controlled Substances Act. Epidiolex is no longer considered a controlled substance.
